Back to stocks
AGMB
AgomAb Therapeutics NV• Healthcare
Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
6
Partial Q3 2026
Total 13F value
$17.4M
Filed positions so far
New positions
3
This quarter
Sold positions
0
This quarter
Top holders
Institutions with disclosed positions in this stock
| Fund | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
Andera Partners | $17.1M | 1.54M | 9.72% | Unchanged |
Crossmark Global Holdings, Inc. | $256K | 23.1K | 0.00% | New Position |
China Universal Asset Management Co., Ltd. | $76K | 7.2K | 0.00% | New Position |
Gamma Investing Llc | $15K | 1.4K | 0.00% | +3.9% |
Pinnacle Wealth Planning Services, Inc. | $821 | 74 | 0.00% | New Position |
Sbi Securities Co., Ltd. | $22 | 2 | 0.00% | Unchanged |